Skip to main content
logo
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
203.21
+13.20 (6.95%)
At close: Oct 5, 2026, 4:00 PM EDT
200.50
-2.71 (-1.33%)
Pre-market: Oct 6, 2026, 8:33 AM EDT

Moderna Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product Sales
2.06B2.08B1.82B2.11B2.96B3.03B3.11B4.96BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Product Sales Growth
-30.22%-31.18%-41.52%-57.47%-39.64%-39.56%-53.40%-43.42%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Grant and Collaboration
164.00M141.00M126.00M121.00M120.00M149.00M127.00M117.00MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Grant and Collaboration Growth
36.67%-5.37%-0.79%3.42%-19.46%4.20%-28.25%-69.53%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Product Sales by Geography

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
1.19B1.21B1.17B1.15B1.58B1.66B1.73B2.28BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
United States Growth
-24.89%-27.16%-32.50%-49.58%-20.01%-8.91%0.35%17.52%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Rest of World
570.00M588.00M603.00M653.00M802.00M798.00M810.00M1.79BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Rest of World Growth
-28.93%-26.32%-25.56%-63.48%-63.63%-66.94%-77.49%-53.39%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Europe
305.00M289.00M50.00M308.00M573.00M573.00M573.00M895.00MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Europe Growth
-46.77%-49.56%-91.27%-65.59%-20.08%-26.25%-57.65%-69.76%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Operating Expense Breakdown

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
2.88B2.93B3.13B3.48B3.82B4.34B4.54B4.83BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Research and Development Growth
-24.61%-32.54%-31.06%-27.93%-21.34%-9.23%-6.23%3.81%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Selling, General, and Administrative
965.00M979.00M1.02B1.06B1.07B1.11B1.17B1.29BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Selling, General, and Administrative Growth
-10.15%-11.96%-13.29%-17.94%-26.13%-26.75%-24.21%-11.07%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade